BioSpace News Archive

RedHill Biopharma Ltd. today announced the publication in the journal Digestive Diseases and Sciences.

Genetic Technologies Limited confirms that the Company’s US patent application for its novel geneType COVID-19 Risk Test has been accepted.

CinCor Pharma, Inc. (“CinCor”), announced today the dosing of the first patient in its Phase 2 clinical trial evaluating CIN-107, a highly selective, oral small molecule inhibitor of aldosterone synthase, in patients with uncontrolled hypertension and elevated plasma aldosterone levels, referred to as the High ALdOsterone (HALO) trial.

Atara Biotherapeutics, Inc. today announced new preclinical and preliminary clinical results for ATA2271, a next-generation autologous chimeric antigen receptor (CAR) T-cell therapy targeting mesothelin (MSLN).

Global spending on medicines — based on invoice price levels — is expected to grow at 3-6% CAGR through 2026 to reach about $1.8 trillion by 2026, including spending on COVID-19 vaccines and novel therapeutics, according to a new report, The Global Spending and Usage of Medicines, released by the IQVIA™ Institute for Human Data Science.

Cyclo Therapeutics Appoints Caroline Hastings, M.D. as Global Principal Investigator for Ongoing TransportNPC™ Study Evaluating Trappsol ® Cyclo™ for the Treatment of Niemann-Pick Disease.

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) today announced that the Company will participate in Alliance Global Partners’ (AGP) Virtual Series on Tuesday December 14, 2021 at 1:00 p.m. Eastern time.

Life Science and Biotech Co-working Incubator LabShares Expands in Newton to Meet Growing Demand.

Pyxis Oncology, Inc. (Nasdaq: PYXS) today announced the appointment of Martina Molsbergen as Interim Chief Business Officer.

Berkeley Lights, Inc., a leader in digital cell biology, announced its participation at the upcoming Antibody Engineering & Therapeutics meeting, being held virtually and in person from Dec. 12-16, 2021, in San Diego, California.